newsfilter
← Latest News
GlobeNewswire·

Alaunos Therapeutics to Present at American Society of Gene and Cell Therapy 25th Annual Meeting

Preclinical data to be presented highlights the potential ability to generate mbIL-15 TCR-T cells targeting hotspot mutations expressed in solid tumors with enhanced survival capacity HOUSTON, May 02, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics,